Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Middle East Current Psychiatry ; 30(1), 2023.
Article in English | Scopus | ID: covidwho-2303192

ABSTRACT

Background: The COVID-19 pandemic is an unprecedented international health crisis, which has invoked massive consequence on healthcare workers' mental health and wellbeing. This study aimed to detect the prevalence of anxiety, depression, and burnout among house officers amid the COVID-19 pandemic in Egypt to assess the effect of this pandemic on their mental health. Results: A total of 254 house officers were included in this study, and their responses were analyzed. Anxiety, burnout, and depression were reported among 35%, 32%, and 22% of participants, respectively. Multivariate regression analysis found that higher levels of overall worry were associated with anxiety, but not depression or burnout. Having a good personal protective equipment attitude was a significant predictor of both anxiety and burnout. Participants with depression had a higher likelihood of also having a burnout, but a lower likelihood of having anxiety. Overall worry related to the pandemic, depression, and clinical burnout status were all significantly associated with anxiety. Conclusions: The study found that anxiety, depression, and burnout are highly prevalent among house officers, who are newly graduated medical professionals. These findings suggest the need for specific programs to address the wellbeing of these individuals during the COVID-19 pandemic. © 2023, The Author(s).

3.
Bone Joint J ; 104-B(6): 645-646, 2022 06.
Article in English | MEDLINE | ID: covidwho-1875056
5.
Bone Jt Open ; 2(10): 865-870, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1477505

ABSTRACT

AIMS: The COVID-19 pandemic drastically affected elective orthopaedic services globally as routine orthopaedic activity was largely halted to combat this global threat. Our institution (University College London Hospital, UK) previously showed that during the first peak, a large proportion of patients were hesitant to be listed for their elective lower limb procedure. The aim of this study is to assess if there is a patient perception change towards having elective surgery now that we have passed the peak of the second wave of the pandemic. METHODS: This is a prospective study of 100 patients who were on the waiting list of a single surgeon for an elective hip or knee procedure. Baseline characteristics including age, American Society of Anesthesiologists (ASA) grade, COVID-19 risk, procedure type, and admission type were recorded. The primary outcome was patient consent to continue with their scheduled surgical procedure. Subgroup analysis was also conducted to define if any specific patient factors influenced decision to continue with surgery. RESULTS: Overall, 88 patients (88%) were happy to continue with their scheduled procedure at the earliest opportunity. Patients with an ASA grade I were most likely to agree to surgery, followed by patients with ASA grades II, then those with grade III (93.3%, 88.7%, and 78.6% willingness, respectively). Patients waitlisted for an injection were least likely to consent to surgery, with just 73.7% agreeing. In all, there was a large increase in the proportion of patient willingness to continue with surgery compared to our initial study during the first wave of the pandemic. CONCLUSION: As COVID-19 lockdown restrictions are lifted after the second peak of the pandemic, we are seeing greater willingness to continue with scheduled orthopaedic surgery, reinforcing a change in patient perception towards having elective surgery. However, we must continue with strict COVID-19 precautions in order to minimize viral transmission as we increase our elective orthopaedic services going forward. Cite this article: Bone Jt Open 2021;2(10):865-870.

6.
J Patient Saf ; 17(2): 81-86, 2021 03 01.
Article in English | MEDLINE | ID: covidwho-1105041

ABSTRACT

ABSTRACT: Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization on March 11, 2020. By mid-March, London had emerged as the epicenter in the United Kingdom, accounting for 45% of the COVID-19-related mortality. A cancer COVID-19-free "cold hub," through National Health Service partnership with independent institutions, was established to maintain a throughput of surgical oncology patients with an accessible triage system for oncologic specialties. The high population density, commuter volume, and rising COVID-19 incidence heightened the challenge of segregating a vulnerable population that was already at high risk for surgical morbidity and mortality.The aim of this review is to report the experience of developing a multicenter COVID-19-free cold hub with the aim of providing safe surgery for surgical oncology patients. We discuss the timeline, structure, and infection control policy and suggest practical points that may guide other health care systems.The surgical oncology hub treated 1542 patients between March 1 and July 1, 2020. There were no cases of COVID-19-related mortality in a 30-day follow-up. Key strategies for the restructuring of the cancer service included the following: (1) formation of an accessible referral pathway, (2) creation and structuring of cold hub hospitals, (3) development of protocols for infection control and preoperative testing, (4) rapid reorganization of services based on initial feedback, and (5) clear communication and leadership.It has been shown that a surgical oncology cold hub with an accessible referral system and an effective system of preoperative screening system can minimize COVID-19 transmission, morbidity, and mortality, in a region with heavy disease prevalence. This structure represents a safe, ethical, and viable system that can be replicated in other health care systems.


Subject(s)
COVID-19 , Cancer Care Facilities/organization & administration , Surgical Oncology/organization & administration , Humans , United Kingdom/epidemiology
7.
Bone Jt Open ; 2(1): 1-2, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1063210
9.
Forest@ ; 17(48-51):48-51, 2020.
Article in Italian | CAB Abstracts | ID: covidwho-976375

ABSTRACT

In these days, the role that fine particles in urban areas could play in facilitating the pandemic spread of the COVID-19 virus is becoming increasingly important. It is also well known that exposure to air pollution and in particular to fine dust favors diseases involving the respiratory system. In this context of strong concern, we argue that urban forests can contribute to reduce the concentrations of particulates or in any increase their dispersion. Not all tree species have the same performance in removing particulates. In this short article, recent works are commented that classify urban forest species according to their ability to reduce particulate matter ambient concentrations, and we conclude highlighting the significant role that urban forests could play in improving air quality and human wellbeing in the future.

10.
Pan African Medical Journal ; 35:1-11, 2020.
Article in French | Scopus | ID: covidwho-961845

ABSTRACT

Patients with cancer are at high risk of developing a severe, even fatal, form of SARS-CoV-2 infection. During this health crisis due to COVID-19 pandemic, this patient population should receive rapid treatment according to the epidemiological context. In Morocco and, in particular, at the Regional Oncology Center in Agadir, a local care group met to propose managent approaches for patients with cancer in these unusual circumstances. The current epidemiological situation in Morocco, and precisely in the southern region, is still under control. The management of patients with cancer should take into account possible loss of chance of full recovery in these patients. We suggest to safeguard continuity of care by adapting treatments to the epidemiological context and the prerogative of governments. © Ghizlane Rais et al.

11.
Bone Joint J ; 102-B(12): 1597-1598, 2020 12.
Article in English | MEDLINE | ID: covidwho-949094
12.
Bone Jt Open ; 1(9): 562-567, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-937201

ABSTRACT

AIMS: The safe resumption of elective orthopaedic surgery following the peak of the COVID-19 pandemic remains a significant challenge. A number of institutions have developed a COVID-free pathway for elective surgery patients in order to minimize the risk of viral transmission. The aim of this study is to identify the perioperative viral transmission rate in elective orthopaedic patients following the restart of elective surgery. METHODS: This is a prospective study of 121 patients who underwent elective orthopaedic procedures through a COVID-free pathway. All patients underwent a 14-day period of self-isolation, had a negative COVID-19 test within 72 hours of surgery, and underwent surgery at a COVID-free site. Baseline patient characteristics were recorded including age, American Society of Anaesthesiologists (ASA) grade, body mass index (BMI), procedure, and admission type. Patients were contacted 14 days following discharge to determine if they had had a positive COVID-19 test (COVID-confirmed) or developed symptoms consistent with COVID-19 (COVID-19-presumed). RESULTS: The study included 74 females (61.2%) and 47 males (38.8%) with a mean age of 52.3 years ± 17.6 years (18 to 83 years). The ASA grade was grade I in 26 patients (21.5%), grade II in 70 patients (57.9%), grade III in 24 patients (19.8%), and grade IV in one patient (0.8%). A total of 18 patients (14.9%) had underlying cardiovascular disease, 17 (14.0%) had pulmonary disease, and eight (6.6%) had diabetes mellitus. No patients (0%) had a positive COVID-19 test in the postoperative period. One patient (0.8%) developed anosmia postoperatively without respiratory symptoms or a fever. The patient did not undergo a COVID-19 test and self-isolated for seven days. Her symptoms resolved within a few days. CONCLUSION: The development of a COVID-free pathway for elective orthopaedic patients results in very low viral transmission rates. While both surgeons and patients should remain vigilant, elective surgery can be safely restarted using dedicated pathways and procedures.Cite this article: Bone Joint Open 2020;1-9:562-567.

13.
Bone Jt Open ; 1(7): 420-423, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-937194

ABSTRACT

The coronavirus 2019 (COVID-19) global pandemic has had a significant impact on trauma and orthopaedic (T&O) departments worldwide. To manage the peak of the epidemic, orthopaedic staff were redeployed to frontline medical care; these roles included managing minor injury units, forming a "proning" team, and assisting in the intensive care unit (ICU). In addition, outpatient clinics were restructured to facilitate virtual consultations, elective procedures were cancelled, and inpatient hospital admissions minimized to reduce nosocomial COVID-19 infections. Urgent operations for fractures, infection and tumours went ahead but required strict planning to ensure patient safety. Orthopaedic training has also been significantly impacted during this period. This article discusses the impact of COVID-19 on T&O in the UK and highlights key lessons learned that may help to proactively prepare for the next global pandemic. Cite this article: Bone Joint Open 2020;1-7:420-423.

14.
Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology ; : 1-8, 2020.
Article in English | Taylor & Francis | ID: covidwho-872858
15.
Bone Joint J ; 102-B(9): 1136-1145, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-829492

ABSTRACT

AIMS: During the COVID-19 pandemic, many patients continue to require urgent surgery for hip fractures. However, the impact of COVID-19 on perioperative outcomes in these high-risk patients remains unknown. The objectives of this study were to establish the effects of COVID-19 on perioperative morbidity and mortality, and determine any risk factors for increased mortality in patients with COVID-19 undergoing hip fracture surgery. METHODS: This multicentre cohort study included 340 COVID-19-negative patients versus 82 COVID-19-positive patients undergoing surgical treatment for hip fractures across nine NHS hospitals in Greater London, UK. Patients in both treatment groups were comparable for age, sex, body mass index, fracture configuration, and type of surgery performed. Predefined perioperative outcomes were recorded within a 30-day postoperative period. Univariate and multivariate analysis were used to identify risk factors associated with increased risk of mortality. RESULTS: COVID-19-positive patients had increased postoperative mortality rates (30.5% (25/82) vs 10.3% (35/340) respectively, p < 0.001) compared to COVID-19-negative patients. Risk factors for increased mortality in patients with COVID-19 undergoing surgery included positive smoking status (hazard ratio (HR) 15.4 (95% confidence interval (CI) 4.55 to 52.2; p < 0.001) and greater than three comorbidities (HR 13.5 (95% CI 2.82 to 66.0, p < 0.001). COVID-19-positive patients had increased risk of postoperative complications (89.0% (73/82) vs 35.0% (119/340) respectively; p < 0.001), more critical care unit admissions (61.0% (50/82) vs 18.2% (62/340) respectively; p < 0.001), and increased length of hospital stay (mean 13.8 days (SD 4.6) vs 6.7 days (SD 2.5) respectively; p < 0.001), compared to COVID-19-negative patients. CONCLUSION: Hip fracture surgery in COVID-19-positive patients was associated with increased length of hospital stay, more admissions to the critical care unit, higher risk of perioperative complications, and increased mortality rates compared to COVID-19-negative patients. Risk factors for increased mortality in patients with COVID-19 undergoing surgery included positive smoking status and multiple (greater than three) comorbidities. Cite this article: Bone Joint J 2020;102-B(9):1136-1145.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Coronavirus Infections/epidemiology , Hip Fractures/surgery , Hospital Mortality , Pneumonia, Viral/epidemiology , Postoperative Complications/mortality , Aged , Aged, 80 and over , Analysis of Variance , Arthroplasty, Replacement, Hip/methods , COVID-19 , Cause of Death , Cohort Studies , Female , Hip Fractures/epidemiology , Humans , Length of Stay , Male , Middle Aged , Multivariate Analysis , Pandemics , Perioperative Care/methods , Postoperative Complications/physiopathology , Reference Values , Risk Assessment , United Kingdom
16.
Bone Joint Res ; 9(8): 531-533, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-751070
17.
Br J Sports Med ; 54(19): 1157-1161, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-744836

ABSTRACT

SARS-CoV-2 is the causative virus responsible for the COVID-19 pandemic. This pandemic has necessitated that all professional and elite sport is either suspended, postponed or cancelled altogether to minimise the risk of viral spread. As infection rates drop and quarantine restrictions are lifted, the question how athletes can safely resume competitive sport is being asked. Given the rapidly evolving knowledge base about the virus and changing governmental and public health recommendations, a precise answer to this question is fraught with complexity and nuance. Without robust data to inform policy, return-to-play (RTP) decisions are especially difficult for elite athletes on the suspicion that the COVID-19 virus could result in significant cardiorespiratory compromise in a minority of afflicted athletes. There are now consistent reports of athletes reporting persistent and residual symptoms many weeks to months after initial COVID-19 infection. These symptoms include cough, tachycardia and extreme fatigue. To support safe RTP, we provide sport and exercise medicine physicians with practical recommendations on how to exclude cardiorespiratory complications of COVID-19 in elite athletes who place high demand on their cardiorespiratory system. As new evidence emerges, guidance for a safe RTP should be updated.


Subject(s)
Betacoronavirus , Coronavirus Infections/complications , Myocarditis/diagnosis , Pneumonia, Viral/complications , Practice Guidelines as Topic , Respiration Disorders/diagnosis , Return to Sport/standards , Athletes , Biomarkers/blood , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Death, Sudden, Cardiac/prevention & control , Electrocardiography , Humans , Myocarditis/blood , Myocarditis/etiology , Myocardium/pathology , Necrosis/etiology , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Respiration Disorders/etiology , SARS-CoV-2 , Sports Medicine/standards , Symptom Assessment , Troponin/blood
18.
Bone Joint J ; 102-B(9): 1109-1110, 2020 09.
Article in English | MEDLINE | ID: covidwho-736472
SELECTION OF CITATIONS
SEARCH DETAIL